Cartesian Therapeutics RNAC
NASDAQ RNAC
$7.47 +0.25 (+3.46%)
As of: Oct 2, 2026 · 10:35 AM EDT

Cartesian Therapeutics (RNAC) Short-Term Debt issuances (2017)

Updated

Cartesian Therapeutics' Short-Term Debt issuances was -$42,000 in Q4 2017.

Analysis

Cartesian Therapeutics (RNAC) Short-Term Debt issuances (2017) Analysis & Trends

For FY2017, Short-Term Debt issuances at Cartesian Therapeutics came in at $20.96 million.

  • Short-Term Debt issuances shows a three-year compound annual growth rate of 67.1% (FY2014 to FY2017).
  • In earlier years, Short-Term Debt issuances was $6.67 million in FY2015 (+48.5%) and $4.49 million in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 707.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cartesian Therapeutics 216.57 Mn 216.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -42,000.00
API Access

Cartesian Therapeutics Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=RNAC&period=max&api_key=YOUR_API_KEY